Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Kindeva Drug Delivery announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global Warming Potential) propellants in its Loughborough, U.K., facility.
read more
Wednesday, January 31, 2024
Kindeva Drug Delivery announced the expansion of its analytical services capabilities — launching a new global business unit offering integrated and stand-alone analytical support to the wider pharmaceutical, biopharmaceutical, and medical device ...
read more
Kindeva Drug Delivery has named Jennifer Riter as Vice President of Analytical Services to head up the recently announced analytical services global business unit.
read more
Kindeva Drug Delivery and H&T Presspart are partnering with Chiesi Group for the installation of a production line for dose counter (DC) and dose indicator (DI) devices.
read more
Kindeva announced the appointment of Mike Cowhig to the role of Chief Legal Officer, to drive legal strategy, enterprise risk management and corporate governance across the organization.
read more
Thursday, September 18, 2025
Kindeva has officially opened its new UK headquarters at Charnwood Campus Science Innovation and Technology Park, Loughborough. The facility represents a significant expansion in Kindeva’s MDI services and will develop and test next-generation ...
read more
Samsung Biologics signed a strategic partnership agreement with Kineta, Inc., a clinical-stage biotech company developing novel immunotherapies in oncology. Samsung Biologics will provide end-to-end CDMO service from cell line development, clinical ...
read more
Monday, December 17, 2018
Kineta Immuno-Oncology has entered into a strategic research collaboration with Pfizer to develop RIG-I agonist immunotherapies for the treatment of cancer.
read more
Kineta Chronic Pain announced the company will extend and expand its research collaboration with Genentech.
read more
King Faisal Specialist Hospital & Research Centre (KFSHRC) and Germfree Laboratories, LLC announced a strategic partnership to develop Saudi Arabia's first fully integrated, modular Advanced Therapy Medicinal Product (ATMP) Manufacturing Campus.
read more
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company has initiated the long-term safety trial of KX-826, a potential first-in-class ...
read more
Tuesday, December 20, 2022
Kite, a Gilead Company and Tmunity Therapeutics (Tmunity), announced that the companies have signed an agreement in which Kite will acquire Tmunity, a clinical-stage, private biotech company focused on next-generation CAR T-therapies and technologies...
read more
Friday, February 23, 2018
Kite and Sangamo announced the companies have entered into a worldwide collaboration using Sangamo’s ZFN technology platform for the development of next-generation ex vivo cell therapies in oncology.
read more
Thursday, August 03, 2017
PharMerica announced that it has entered into a definitive merger agreement pursuant to which a newly formed company controlled by KKR, with Walgreens Boots Alliance as a minority investor, will acquire PharMerica.
read more
Wednesday, April 01, 2020
Kleo has entered into a research collaboration with GCLC to rapidly advance testing of both advanced technology platforms in combination as a potential therapy for COVID-19 patients.
read more